Using both short hairpin RNA (shRNA) and dBRD9 chemical degradation, Michel et al. demonstrated that BRD9 suppression caused rapid attenuation of proliferation in these cancer types, once again identifying the potential utility for BRD9 as a therapeutic target [107]. This evidence concerns the gene BRD9 and cancer.